Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2CNS 2Breast 2Other solid neoplasm 1Other 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 2Lymphedema 1Atrophy 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Lasers × Breast × Clear all
NCT04081805 2025-04-24

EPMLARF

Federal University of São Paulo

Phase NA Active not recruiting
195 enrolled
Breast

Atrophy, Breast Neoplasms

NCT00852930 2017-04-11

Low Level Laser Treatment and Breast Cancer Related Lymphedema

Vanderbilt University

Phase 4 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡